Microglial activation depends on beta-amyloid conformation: Role of the formylpeptide receptor 2

Journal of Neurochemistry

Volumn 114, Issue 2, 2010, Pages 576-586

  Heurtaux, Tony ^a   Michelucci, Alessandro ^a   Losciuto, Sophie ^a   Gallotti, Christian ^a   Felten, Paul ^a   Dorban, Gauthier ^a   Grandbarbe, Luc ^a   Morga, Eleonora ^a   Heuschling, Paul ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Alzheimer's disease; beta amyloid; brain; immune cells; inflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOMER; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; INFLAMMATION; MICROGLIA; MOUSE; NEUROMODULATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; BIOPOLYMERS; CELL LINE; INFLAMMATION; MICE; MICE, INBRED C57BL; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN CONFORMATION; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

MURINAE;

EID: 77953818590     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06783.x     Document Type: Article

References (62)

1. Arthur J. S. (2008) MSK activation and physiological roles. Front. Biosci. 13, 5866 5879.
2. Bae Y. S., Lee H. Y., Jo E. J., Kim J. I., Kang H. K., Ye R. D., Kwak J. Y. Ryu S. H. (2004) Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173, 607 614.
3. von Bernhardi R., Ramírez G., Toro R. Eugenín J. (2007) Pro-inflammatory conditions promote neuronal damage mediated by amyloid precursor protein and decrease its phagocytosis and degradation by microglial cells in culture. Neurobiol. Dis. 26, 153 164.
4. Bolmont T., Haiss F., Eicke D., Radde R., Mathis C. A., Klunk W. E., Kohsaka S., Jucker M. Calhoun M. E. (2008) Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 28, 4283 4292.
5. Brandenburg L. O., Konrad M., Wruck C. J., Koch T., Lucius R. Pufe T. (2010) Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. J. Neurochem. 113, 749 760.
6. Briers T. W., Desmaretz C. Vanmechelen E. (1994) Generation and characterization of mouse microglial cell lines. J. Neuroimmunol. 52, 153 164.
7. Campa V. M., Iglesias J. M., Carcedo M. T., Rodriguez R., Riera J., Ramos S. Lazo P. S. (2005) Polyinosinic acid induces TNF and NO production as well as NF-kappaB and AP-1 transcriptional activation in the monocytemacrophage cell line RAW 264.7. Inflamm. Res. 54, 328 337.
8. Choi K., Zhuang H., Crain B. Dore S. (2008) Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls. J. Neuroimmunol. 195, 81 87.
9. Cui Y. H., Le Y., Gong W., Proost P., Van Damme J., Murphy W. J. Wang J. M. (2002a) Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168, 434 442.
10. Cui Y., Le Y., Yazawa H., Gong W. Wang J. M. (2002b) Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 72, 628 635. Review.
11. Cui Y., Hou X., Chen J., Xie L., Yang L. Le Y. (2010) Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes. J. Nutr. 140, 377 381.
12. Delgado M., Varela N. Gonzalez-Rey E. (2008) Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels. Glia 56, 1091 1103.
13. Du Yan S., Zhu H., Fu J., Yan S. F., Roher A., Tourtellotte W. W., Rajavashisth T., Chen X., Godman G. C., Stern D. others 1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 5296 5301.
14. Eikelenboom P., Veerhuis R., Familian A., Hoozemans J. J., van Gool W. A. Rozemuller A. J. (2008) Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications. Neurodegener. Dis. 5, 190 193.
15. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C. Loike J. D. (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382, 716 719.
16. Farfara D., Lifshitz V. Frenkel D. (2008) Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J. Cell Mol. Med. 12, 762 780.
17. Findeis M. A. (2007) The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacol. Ther. 116, 266 286.
18. Giuffrida M. L., Caraci F., Pignataro B. et al. (2009) Beta-amyloid monomers are neuroprotective. J. Neurosci. 29, 10582 10587.
19. Ho G. J., Drego R., Hakimian E. Masliah E. (2005) Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr. Drug Targets Inflamm. Allergy 4, 247 256.
20. Hoozemans J. J., Chafekar S. M., Baas F., Eikelenboom P. Scheper W. (2006) Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease. Curr. Med. Chem. 13, 2599 2605.
21. Hung L. W., Ciccotosto G. D., Giannakis E., Tew D. J., Perez K., Masters C. L., Cappai R., Wade J. D. Barnham K. J. (2008) Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J. Neurosci. 28, 11950 11958.
22. Iribarren P., Zhou Y., Hu J., Le Y. Wang J. M. (2005a) Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol. Res. 31, 165 176. Review.
23. Iribarren P., Chen K., Hu J., Zhang X., Gong W. Wang J. M. (2005b) IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia. J. Immunol. 175, 6100 6106.
24. Jang S., Kelley K. W. Johnson R. W. (2008) Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl Acad. Sci. USA 105, 7534 7539.
25. Jeon S. B., Yoon H. J., Park S. H., Kim I. H. Park E. J. (2008) Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J. Immunol. 181, 8077 8087.
26. Jung Y. J., Isaacs J. S., Lee S., Trepel J. Neckers L. (2003) IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17, 2115 2117.
27. Kam A. Y., Tse T. T., Kwan D. H. Wong Y. H. (2007) Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells. Cell. Signal. 19, 2106 2117.
28. Kim Y. S. Joh T. H. (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp. Mol. Med. 38, 333 347.
29. Kim S. D., Kim J. M., Jo S. H., Lee H. Y., Lee S. Y., Shim J. W., Seo S. K., Yun J. Bae Y. S. (2009) Functional expression of formyl peptide receptor family in human NK cells. J. Immunol. 183, 5511 5517.
30. Koenigsknecht-Talboo J. Landreth G. E. (2005) Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 25, 8240 8249.
31. Le Y., Wang J. M., Liu X., Kong Y., Hou X., Ruan L. Mou H. (2007) Biologically active peptides interacting with the G protein-coupled formylpeptide receptor. Protein Pept. Lett. 14, 846 853. Review.
32. Lesne S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M. Ashe K. H. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352 357.
33. Lorton D., Schaller J., Lala A. De Nardin E. (2000) Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. Neurobiol. Aging 21, 463 473.
34. Malaplate-Armand C., Florent-Bechard S., Youssef I., Koziel V., Sponne I., Kriem B., Leininger-Muller B., Olivier J. L., Oster T. Pillot T. (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol. Dis. 23, 178 189.
35. Malm T. M., Koistinaho M., Parepalo M., Vatanen T., Ooka A., Karlsson S. Koistinaho J. (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis. 18, 134 142.
36. McGeer P. L., Rogers J. McGeer E. G. (2006) Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 9, 271 276.
37. Michelucci A., Heurtaux T., Grandbarbe L., Morga E. Heuschling P. (2009) Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-β. J. Neuroimmunol. 210, 3 12.
38. Migeotte I., Communi D. Parmentier M. (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17, 501 519.
39. Mrak R. E. Griffin W. S. (2007) Common inflammatory mechanisms in Lewy body disease and Alzheimer disease. J. Neuropathol. Exp. Neurol. 66, 683 686.
40. Park H., Park S. G., Kim J., Ko Y. G. Kim S. 2002) Signaling pathways for TNF production induced by human aminoacyl-tRNA synthetase-associating factor, p43. Cytokine 20 : 148 153.
41. Parvathy S., Rajadas J., Ryan H., Vaziri S., Anderson L. Murphy G. M. Jr. (2008) Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells. Neurobiol. Aging 30, 1792 1804.
42. Patel N. S., Paris D., Mathura V., Quadros A. N., Crawford F. C. Mullan M. J. (2005) Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J. Neuroinflammation 2, 9.
43. Ramírez G., Rey S. von Bernhardi R. (2008) Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP-{244-C} and Abeta-neurotoxicity in hippocampal cultures. J. Alzheimers Dis. 15, 45 59.
44. Rogers J. Lue L. F. (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39, 333 340.
45. Rogers J., Strohmeyer R., Kovelowski C. J. Li R. (2002) Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40, 260 269.
46. Rojo L. E., Fernandez J. A., Maccioni A. A., Jimenez J. M. Maccioni R. B. (2008) Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch. Med. Res. 39, 1 16.
47. Sastre M., Klockgether T. Heneka M. T. (2006) Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int. J. Dev. Neurosci. 24, 167 176.
48. Selkoe D. J. (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106 113.
49. Sondag C. M., Dhawan G. Combs C. K. (2009) Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J. Neuroinflammation 6, 1.
50. Stenfeldt A. L., Karlsson J., Wennerås C., Bylund J., Fu H. Dahlgren C. (2007) Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30, 224 229.
51. Streit W. J. (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133 139.
52. Streit W. J., Braak H., Xue Q. S. Bechmann I. (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475 485.
53. Tahara K., Kim H. D., Jin J. J., Maxwell J. A., Li L. Fukuchi K. (2006) Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129, 3006 3019.
54. Tamagno E., Bardini P., Guglielmotto M., Danni O. Tabaton M. (2006) The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41, 202 212.
55. Tsatsanis C., Androulidaki A., Venihaki M. Margioris A. N. (2006) Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654 1661.
56. Ulivi V., Giannoni P., Gentili C., Cancedda R. Descalzi F. (2008) p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J. Cell. Biochem. 104, 1393 1406.
57. Weber W. M., Hunsaker L. A., Gonzales A. M., Heynekamp J. J., Orlando R. A., Deck L. M. Vander Jagt D. L. (2006) TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochem. Pharmacol. 72, 928 940.
58. Weisman D., Hakimian E. Ho G. J. (2006) Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam. Horm. 74, 505 530.
59. White J. A., Manelli A. M., Holmberg K. H., Van Eldik L. J. Ladu M. J. (2005) Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol. Dis. 18, 459 465.
60. Wisniewski T. Konietzko U. (2008) Amyloid-beta immunisation for Alzheimer's disease. Lancet Neurol. 7, 805 811.
61. Wong C. K., Zhang J. P., Ip W. K. Lam C. W. (2002) Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils. Clin. Exp. Immunol. 128, 483 489.
62. Zhu Y., Hou H., Nikolic W. V., Ehrhart J., Rrapo E., Bickford P., Giunta B. Tan J. (2008) CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation. PLoS ONE 3, e2135.